HEALTHCARE
CLINICAL TRIAL MANAGEMENT SYSTEM/CTMS MARKET GLOBAL FORECASTS TO 2021
CLINICAL TRIAL MANAGEMENT SYSTEM/CTMS MARKET GLOBAL FORECASTS TO 2021
By End-User (Pharmaceutical & Biopharma, Medical Device Companies, Cros), Delivery Mode (Web Hosted, OnPremise, Cloud-Based), Type (Enterprise, Site), Component (Software, Services)
REPORT OVERVIEW 1.1
OBJECTIVES OF THE STUDY •
To define, describe, and forecast the global CTMS market on the basis of enduser, delivery mode , components and type
•
To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and challenges)
•
To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
•
To provide a five-year forecast of CTMS market, in terms of revenue, with respect to four main regions, namely, North America, Europe, Asia-Pacific, and the Rest of the World
•
To provide insights about the shares of key players in global CTMS market
•
To strategically analyse micro-markets with respect to their individual growth trends, future prospects, and contributions to the total market
•
To analyse opportunities in the market for stakeholders and provide details of the competitive landscape for market leader
•
To strategically profile the key players and comprehensively analyse their market shares and core competencies
sales@marketsandmarkets.com
www.marketsandmarkets.com
1
INTRODUCTION
•
1.2
To track and analyse competitive developments such as new product launches and product enhancements; agreements, partnerships, and collaborations; mergers and acquisitions; and R&D activities in the CTMS solutions market
MARKET DEFINITION
•
A clinical trial management system (CTMS) is an integrated solution consisting of different modules. CTMS modules streamline the clinical trial process and maximize operational efficiency throughout clinical studies. This helps to improve efficiency and reduce the overall cost of conducting clinical trials.
•
CTMS assist companies involved in clinical trial such as CROs; medical device, pharma and biotechnology companies to plan, track, manage clinical trials and their progress. Furthermore, it also ensures financial management of clinical trials and investigator payments
1.3
MARKETS COVERED • MARKET SCOPE:
•
The study covers market for only CTMS solutions. The research report categorizes the CTMS market into the following segments:
1.4 •
•
CTMS Market, By Type
•
CTMS Market, By Delivery Mode
•
CTMS Market, By End-user
•
CTMS Market, By Component
GEOGRAPHIC SCOPE The research report categorizes the CTMS market into the following geographies: • EUROPE
NORTH AMERICA ASIA-PACIFIC
REST OF THE WORLD
•
sales@marketsandmarkets.com
www.marketsandmarkets.com
2
INTRODUCTION
1.5
YEARS CONSIDERED FOR THE STUDY 2016–2021
• 2016 2015 2014
HISTORICAL YEAR
BASE YEAR
ESTIMATED YEAR
FORECAST PERIOD
•
1.6
MARKET SEGMENTATION •
BY DELIVERY MODE • Web-Based (Hosted) CTMS
CTMS MARKET
BY REGION • North America • Europe
• Licensed Enterprise (On Premise) CTMS
• Asia-Pacific • Rest of the World
• Cloud-Based (SaaS) CTMS
BY COMPONENT
BY END USER
• Software
• Pharmaceutical and Biopharmaceutical Companies
• Services
BY TYPE • Enterprise CTMS • Site CTMS
•
• Contract Research organizations • Medical Device Companies • Others*
*Others: The other end-user segment include hospitals and academic research institutes
sales@marketsandmarkets.com
www.marketsandmarkets.com
3
RESEARCH METHODOLOGY
2.1
RESEARCH DESIGN
•
RESEARCH HISTORICAL DATA FOR THE CTMS MARKET
INFLUENCING FACTORS (Market Trends and Dynamics)
METHODOLOGY
MARKET SHARE ANALYSIS
COMPETITIVE LANDSCAPE
GEOGRAPHICAL ANALYSIS
COMPANY REVENUES & R&D EXPENSES
MARKET DRIVERS: • Increasing research and development expenditure of life science and clinical research industry • Rising number of clinical trials • New product launches • Increasing customer base owing to adoption of CTMS solutions
MARKET RESTRAINTS:
MARKET OPPORTUNITIES:
•
Lack of skilled professionals
•
•
Budget constraints
Use of platform-as-a-service (PaaS) platform and mobile computing
•
Increasing outsourcing of clinical trial to CROs in Asian countries
TREND: Collaborative CTMS: Integration of CTMS with other software such as HIS, EMR and EDC
REGIONAL ANALYSIS: Market Dynamics and business environment in North America, Europe, Asia-Pacific, and the Rest of the World
HISTORICAL DATA OF THE MARKET
MARKET SIZE & FORECAST, BY REGION
INDUSTRY TRENDS
ARRIVE AT THE MARKET SIZE, SHARE, AND CAGR FOR THE CTMS MARKET
FORECAST (2016–2021)
•
2.1.1 SECONDARY DATA •
This research study involves extensive usage of secondary sources, directories, and databases (such as Hoovers, Bloomberg Business, Factiva, OnSource, and Avention)
•
The secondary sources for this research study include government sources [such as the Healthcare Information Management Systems Society (HIMSS) publications, the EU Industrial R&D Investment Scoreboard, and ClinicalTrials.gov]; corporate filings (annual reports, SEC filings, investor presentations, and financial statements); and trade, business, and professional associations
•
Secondary data was collected and analyzed to arrive at the CTMS market size, which was validated by primary research
sales@marketsandmarkets.com
www.marketsandmarkets.com
4
RESEARCH METHODOLOGY
2.1.1.1 KEY DATA FROM SECONDARY SOURCES SECONDARY SOURCES
PARAMETERS
•
• • • • • •
Company Financials Magazines Journals Press Releases Paid Databases MarketsandMarkets Data Repository
COMPANY REVENUES
• • • •
Annual Reports Company Websites Public Databases MarketsandMarkets Data Repository
QUALITATIVE INFORMATION (Market Dynamics and Trends)
• • • • • •
Company Websites Annual Reports Press Releases Research Journals Webinars MarketsandMarkets Data Repository
• • •
Company Websites Annual Reports Public Databases (HIMSS, Drug Information Association, EFPIA, PhRMA, and ClinicalTrials.gov, among others) MarketsandMarkets Data Repository
MARKET SIZE OF CTMS SOLUTION
QUANTITATIVE INFORMATION (Market Dynamics and Trends)
•
•
2.1.2 PRIMARY DATA •
Extensive primary research was conducted after acquiring basic knowledge of the life science and clinical data sciences market scenario
•
Primary interviews were conducted with market experts from both the demand side (pharmaceuticals and biopharma companies, academic institutions, clinical research organizations, consulting service companies, and hospitals) and the supply side (CTMS software vendors and distributors) across major geographies—the U.S., Europe, Asia-Pacific, Latin America, Africa, and the Middle East
•
Primary data was collected through telephonic interviews, e-mail, online survey and professional networking websites
sales@marketsandmarkets.com
www.marketsandmarkets.com
5
RESEARCH METHODOLOGY
2.1.2.1 KEY DATA FROM PRIMARY SOURCES TYPES
•
GEOGRAPHIC SPLIT
GLOBAL MARKET SIZE
PARAMETERS
DATA
Overall market in 2016 CAGR of each region in the forecast period (2016–2021)
The global market size for 2016 CAGR for the forecast period (2016–2021)
Global CTMS market, by region [North America, Europe, Asia-Pacific, and the Rest of the World (RoW)]
Global CTMS market CTMS market, by Segment
Enterprise CTMS, Site CTMS Web-Based (Hosted) CTMS, Licensed Enterprise (On Premise) CTMS, CloudBased (SaaS) CTMS
MARKET SPLIT
Pharmaceutical and Biopharmaceutical Companies, Contract Research organizations, Medical Device Companies, Others
CTMS Market, by Type CTMS Market, by Delivery Mode CTMS Market, by End-user CTMS Market, by Component CTMS Market, by Region
Software, Services
•
2.2.1 MARKET SIZE ESTIMATION STEPS •
Generating Sample Size (Using Secondary/Primary Research and Internal Database)
List generation of end users* of CTMS software across the globe
Preparation of a questionnaire to understand the: • Market dynamics (drivers, restraints, opportunities, and challenges) • Market size (USD Value) • Growth forecasts and trends • Demand scenario across the globe
List generation of software developers and service providers in the global CTMS market
Market Sizing Methodology
1
2 3
Conducting interviews
A sample study method was used for conducting primary research/interviews (Step 1–Step 5)
The annual spending pattern on CTMS software was studied across all the end users (Step 1 –Step 5)
4
Tabulation of the collected data
5
Analysis and report preparation (PDF )
Sample data was extrapolated at the geographic level Calculations for market size were done using **geographic-level data
•
*End users include pharmaceutical and biopharmaceutical companies, clinical research organizations, consulting service companies, academic research institutes, and hospitals **The U.S., Europe, Asia-Pacific and the Rest of the World
sales@marketsandmarkets.com
www.marketsandmarkets.com
6
RESEARCH METHODOLOGY
2.2.2 END-USER ANALYSIS •
The end-user analysis approach was utilized to estimate the overall market size of the CTMS market.
•
The end users were interviewed to get insights on: •
Target geographies: The U.S., Europe, Asia-Pacific and the Rest of the World
•
Average spending on CTMS software, annually
•
Average spending on CTMS software per clinical trial by pharmaceutical and biopharmaceutical companies and CROs
•
Key decision makers and influencers demanding the use CTMS software
•
Market dynamics
•
End users’ perspective on the quality and prices of software as well as services offered by different software vendors in CTMS market • Pharmaceutical & Biopharmaceutical Companies
Others
END USERS OF CTMS SOFTWARE
Contract Research Organizations
Medical Device Companies
•
sales@marketsandmarkets.com
www.marketsandmarkets.com
7
RESEARCH METHODOLOGY
2.2.2.1 BOTTOM-UP APPROACH – SUPPLY SIDE •
Secondary & Primary Research
Global CTMS market (USD million)
Size Estimation of the CTMS Market (Value Analysis)
Market Size Is Validated Through Primaries (Demand- and Supplyside Experts)
Extrapolation of the market to 100% to arrive at the size of the global CTMS market Mapping the revenues, by company, to the extent of 75% of the market covered Mapping the revenue generated by sales and services of CTMS solution, by company Generating the list of top 10-15 players operating in the CTMS market
PRIMARY SOURCES: Demand- and Supply-side Experts SECONDARY SOURCES: Annual Reports, Presentations, Press Releases, Journals, Paid Databases, MarketsandMarkets Repository, National Institutes of Health (NIH), ClinicalTrials.gov, FDA, WHO, International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), Eurostat - European Commission, Pharmaceutical Research and Manufacturers of America (PhRMA), among others
•
2.2.2.1 BOTTOM-UP APPROACH – DEMAND SIDE •
Secondary & Primary Research
Global CTMS Market Size (USD)
Size Estimation of the CTMS Market (Value Analysis)
PRIMARY RESEARCH : Industry Experts/Key Opinion Leaders (KOLs)/Subject Matter Experts (SMEs) from the Demand and Supply Sides
Extrapolation of the Above Data to Geographylevel Based on the Total Number of End Users in a Geography Estimation of Annual Spending on CTMS Software and Services by Each End-user Category Classification of End Users into Tier I, Tier II, and Others Based on Revenue Generated
SECONDARY RESEARCH: Annual Reports, Presentations, Press Releases, Journals, Paid Databases, MarketsandMarkets Repository, National Institutes of Health (NIH), ClinicalTrials.gov, FDA, WHO, International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), Eurostat - European Commission, Pharmaceutical Research and Manufacturers of America (PhRMA), among others
List Generation of End Users, by Geography
•
sales@marketsandmarkets.com
www.marketsandmarkets.com
8
RESEARCH METHODOLOGY
2.2.2.2 TOP-DOWN APPROACH Size Estimation of the CTMS Market
Secondary & Primary Research
•
Global CTMS market (USD million) Percent Split for the Market Size of the Segments (Type, Delivery Mode, Component) of the Total Market
PRIMARY RESEARCH : Industry Experts/Key Opinion Leaders (KOLs)/Subject Matter Experts (SMEs) from the Demand and Supply Sides
Global CTMS Solutions Market Size, By Type, Delivery Mode, Component
a Region-wise Percentage Split for the Market Size of Each Type, Delivery Mode, Component Segment
SECONDARY RESEARCH: Healthcare Information Management Systems Society (HIMSS) Publications, the EU Industrial R&D Investment Scoreboard, ClinicalTrials.gov, Annual Reports, SEC Filings, Investors Presentations, Financial Statements, Magazines, Paid Databases, and MarketsandMarkets Repository
Region-wise market size for each segment (USD million)
•
2.2.3 PRIMARY RESEARCH – SAMPLING FRAME •
This research study involved interviews with the below-mentioned experts. The research phase aimed to obtain insights/information on specific requirements of the client (mentioned in the scope) and to fill market data gaps.
•
Key Opinion Leaders
U.S.
Europe
Rest of the World (RoW)
Total
Presidents, CEOs, Vice Presidents, Directors, General Managers, and Heads of Life Science Business Segments
8
2
2
12
13
6
1
20
14
6
3
23
35
14
6
55
Supply Side Product/Sales/Marketing/Business Development/Client Portfolio Managers or Specialists
Vice Presidents and Global Heads of Clinical Data Management, Senior Principal Clinical Scientists, Director Biostatistics and Data Management,
Demand Side
and Clinical Data Compliance and Quality Leads, among others
Total
•
Approximately 70% of the proposed interviews were telephonic/in-person/focus group interviews
•
The remaining 30% of the interviews were web-based interviews
•
The respondents were screened by the qualification criteria set for the study
sales@marketsandmarkets.com
www.marketsandmarkets.com
9
RESEARCH METHODOLOGY
2.3
MARKET BREAKDOWN AND DATA TRIANGULATION
• DEMAND SIDE
PRIMARY SOURCES
SECONDARY SOURCES
INTERVIEWS WITH: • • • •
Vice Presidents and Global Heads of Clinical Data Management Senior Principal Clinical Scientists Director Biostatistics and Data Management Clinical Data Compliance and Quality Leads Institutions
SUPPLY SIDE
INTERVIEWS WITH: •
Presidents, CEOs, Vice Presidents, Directors, General Managers, and Heads of Life Science Business Segments
•
Product/Sales/Marketing/Business Development/Client Portfolio Managers or Specialists
•
Business Intelligence Consultants
Key Players
MnM KNOW*
PRIMARY SOURCE
DATA TRIANGULATION
SECONDARY SOURCE
• • • • •
INFORMATION SOURCED
Competitive Landscape
Drivers and Restraints
Annual Reports, Presentations, Websites, and Press Releases of Top Players; News Articles; Journals; and Paid Databases
•
ClinicalTrials.gov National Institutes of Health (NIH) National Commission for Health and Family Planning (NCHFP) U.S. Food and Drug Administration International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) Eurostat - European Commission
Opportunities and Challenges
Forecast
Market Size (2016) and Market Share (2015)
Regional Analysis
MnM KNOW* stands for ‘MarketsandMarkets Knowledge Asset Management' framework. In this context, it stands for the existing market research knowledge repository of over 5,000 granular markets, our flagship competitive intelligence and market research platform "RT", subject-matter experts, and independent consultants. MnM KNOW acts as an independent source that helps us validate information gathered from primary and secondary sources.
•
sales@marketsandmarkets.com
www.marketsandmarkets.com
10
TABLE OF CONTENTS
1 INTRODUCTION •
1.1
OBJECTIVES OF THE STUDY
•
1.2
MARKET DEFINITION
•
1.3
MARKETS COVERED
•
1.4
GEOGRAPHIC SCOPE
•
1.5
YEARS CONSIDERED FOR THE STUDY
•
1.6
MARKET SEGMENTATION
2
RESEARCH METHODOLOGY •
2.1 •
RESEARCH DESIGN 2.1.1
• •
2.1.1.1 2.1.2
• •
•
3
2.2
SECONDARY DATA KEY DATA FROM SECONDARY SOURCES
PRIMARY DATA 2.1.2.1
KEY DATA FROM SECONDARY SOURCES
MARKET SIZE ESTIMATION
•
2.2.1
MARKET SIZE ESTIMATION STEPS
•
2.2.2
END-USER ANALYSIS
•
2.2.3
BOTTOM-UP APPROACH
•
2.2.4
TOP-UP APPROACH
•
2.2.5
PRIMARY RESEARCH – SAMPLING FRAME
2.3
DATA TRIANGULATION AND RESEARCH ASSUMPTIONS
EXECUTIVE SUMMARY •
3.1
INTRODUCTION
•
3.2
CTMS MARKET, BY END-USER (2016)
•
3.3
CTMS MARKET, BY DELIVERY MODE, 2016 VS. 2021
•
3.4
CTMS MARKET SHARE, BY TYPE, 2016
•
3.5
CTMS MARKET SHARE, BY COMPONENT, 2016
•
3.6
CTMS MARKET, BY GEOGRAPHY
•
3.7
COMPETITIVE LANDSCAPE
sales@marketsandmarkets.com
www.marketsandmarkets.com
11
TABLE OF CONTENTS
4
PREMIUM INSIGHTS •
4.1
MARKET OPPORTUNITIES FOR GROWTH IN CTMS MARKET (2016-2021)
•
4.2
ASIA-PACIFIC TO LEAD THE MARKET GROWTH FOR CTMS DURING THE FORECAST PERIOD
•
4.3
GLOBAL CTMS MARKET, BY END-USER AND MODE OF DELIVERY (2016)
•
4.4
GLOBAL CTMS MARKET, BY COMPONENT AND TYPE, 2016 VS. 2021
5
MARKET DYNAMICS •
5.1
OVERVIEW
•
5.2
KEY MARKET DRIVERS
•
•
•
•
5.2.1
RISING R&D EXPENDITURE OF PHARMACEUTICAL, LIFE SCIENCE AND CLINICAL RESEARCH INDUSTRIES
•
5.2.2
RISING NUMBER OF CLINICAL TRIALS
•
5.2.3
NEW PRODUCT LAUNCHES
•
5.2.4
INCREASING CUSTOMER BASE OWING TO ADOPTION OF CTMS SOLUTIONS
•
5.2.5
RISING ADOPTION OF CTMS DUE TO ADVANTAGES PROVIDED BY IT
5.3 •
5.3.1
BUDGET CONSTRAINTS
•
5.3.2
LACK OF SKILLED PROFESSIONALS
5.4
KEY MARKET OPPORTUNITIES
•
5.4.1
INCREASING OUTSOURCING OF CLINICAL TRIALS TO CROS IN ASIAN COUNTRIES
•
5.4.2
USE OF PLATFORM-AS-A-SERVICE (PAAS) PLATFORM AND MOBILE COMPUTING
5.5 •
6
KEY MARKET RESTRAINTS
KEY MARKET TRENDS 5.5.1
COLLABORATIVE CTMS: INTEGRATION OF CTMS WITH OTHER SOFTWARE SUCH AS HIS, EMR AND EDC
CTMS MARKET, BY END-USER •
6.1
OVERVIEW
•
6.2
PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES
•
6.3
CONTRACT RESEARCH ORGANIZATIONS
•
6.4
MEDICAL DEVICE COMPANIES
•
6.5
OTHERS
sales@marketsandmarkets.com
www.marketsandmarkets.com
12
TABLE OF CONTENTS
7
CTMS MARKET, BY DELIVERY MODE •
7.1
OVERVIEW
•
7.2
WEB-BASED (HOSTED) CTMS
•
7.3
LICENSED ENTERPRISE (ON PREMISE) CTMS
•
7.4
CLOUD-BASED (SAAS) CTMS
8
CTMS MARKET, BY COMPONENT •
8.1
OVERVIEW
•
8.2
SOFTWARE
•
8.3
SERVICES
9
CTMS MARKET, BY COMPONENT •
9.1
OVERVIEW
•
9.2
ENTERPRISE CTMS
•
9.3
SITE CTMS
10
GEOGRAPHIC ANALYSIS
•
10.1
OVERVIEW
•
10.2
NORTH AMERICA
•
•
•
•
10.2.1
SIGNIFICANT NUMBER OF ONGOING CLINICAL TRIALS IN THE REGION
•
10.2.2
RISING GOVERNMENT SUPPORT FOR CLINICAL TRIAL
10.3
EUROPE
•
10.3.1
GOVERNMENT SUPPORT
•
10.3.2
GROWTH IN THE BIOSIMILARS MARKET CALLS FOR INCREASED CLINICAL ACTIVITIES
10.4
ASIA-PACIFIC
•
10.4.1
INCREASING NUMBER OF CLINICAL TRIALS IN THE REGION
•
10.4.2
GOVERNMENT INITIATIVES IN THE REGION
10.5
REST OF THE WORLD
•
10.5.1
FAVOURABLE CLINICAL TRIALS REGULATION IN BRAZIL AND MEXICO
•
10.5.2
INVESTMENT IN MIDDLE EAST
sales@marketsandmarkets.com
www.marketsandmarkets.com
13
TABLE OF CONTENTS
11
COMPETITIVE INTELLIGENCE
•
11.1
GLOBAL CTMS SOLUTIONS MARKET SHARE, BY KEY PLAYER, 2015
•
11.2
COMPETITIVE PROFILE MATRIX – TOP THREE PLAYERS
•
11.3
COMPETITIVE SITUATION AND TRENDS
12
COMPANY PROFILES AND ANALYSIS •
(Overview, Financials, Products & Services, Strategy, and Developments)*
•
12.1
OVERVIEW
•
12.2
ORACLE CORPORATION
•
12.3
MEDIDATA SOLUTIONS, INC.
•
12.4
PAREXEL INTERNATIONAL CORPORATION
•
12.5
BIOCLINICA, INC. (BIOCLINICA)
•
12.6
BIO-OPTRONICS, INC.
•
12.7
MERGE HEALTHCARE INCORPORATED (AN IBM COMPANY)
•
12.8
DATATRAK INTERNATIONAL, INC.
•
12.9
VEEVA SYSTEMS, INC.
•
12.10 DSG INC. (DOCUMENT SOLUTIONS GROUP)
•
12.11 ECLINFORCE, INC.
•
12.12 ERT
•
12.13 FORTE RESEARCH SYSTEMS, INC.
•
12.14 MEDNET SOLUTIONS, INC.
•
13
*Details on overview, financials, product & services, strategy, and developments might not be captured in case of unlisted companies.
APPENDIX
•
13.1
DISCUSSION GUIDE
•
13.2
INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
•
13.3
KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
•
13.4
AVAILABLE CUSTOMIZATIONS
•
13.5
RELATED REPORTS
•
sales@marketsandmarkets.com
www.marketsandmarkets.com
14
LIST OF TABLES
• TABLE - 1
IMPACT ANALYSIS: DRIVERS
• TABLE - 2
IMPACT ANALYSIS: RESTRAINTS
• TABLE - 3
CTMS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
• TABLE - 4
CTMS MARKET SIZE FOR PHARMA AND BIOPHARMA INDUSTRY, BY REGION, 2014-2021 (USD MILLION)
• TABLE - 5
CTMS MARKET SIZE FOR CONTRACT RESEARCH ORGANIZATIONS (CRO), BY REGION, 2014-2021 (USD MILLION)
• TABLE - 6
CTMS MARKET SIZE FOR MEDICAL DEVICE MANUFACTURERS, BY REGION, 2014-2021 (USD MILLION)
• TABLE - 7
CTMS MARKET SIZE FOR OTHERS, BY REGION, 2014-2021 (USD MILLION)
• TABLE - 8
GLOBAL CTMS MARKET SIZE, BY MODE OF DELIVERY, 2014–2021 (USD MILLION)
• TABLE - 9
WEB-HOSTED (ON-DEMAND) CTMS MARKET SIZE, BY GEOGRAPHY, 2014–2021 (USD MILLION)
• TABLE - 10
LICENSED ENTERPRISE (ON-PREMISE) CTMS MARKET SIZE, BY GEOGRAPHY, 2014–2021 (USD MILLION)
• TABLE - 11
CLOUD-BASED (SAAS) MARKET SIZE, BY GEOGRAPHY, 2014–2021 (USD MILLION)
• TABLE - 12
GLOBAL CTMS MARKET SIZE, BY COMPONENT, 2014–2021 (USD MILLION)
• TABLE - 13
SOFTWARE MARKET SIZE, BY GEOGRAPHY, 2014–2021 (USD MILLION)
• TABLE - 14
SERVICES MARKET SIZE, BY GEOGRAPHY, 2014–2021 (USD MILLION)
• TABLE - 15
GLOBAL CTMS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
• TABLE - 16
ENTERPRISE CTMS MARKET SIZE, BY GEOGRAPHY, 2014–2021 (USD MILLION)
• TABLE - 17
SITE CTMS MARKET SIZE, BY GEOGRAPHY, 2014–2021 (USD MILLION)
• TABLE - 18
CTMS MARKET SIZE, BY GEOGRAPHY, 2014–2021 (USD MILLION)
• TABLE - 19
NORTH AMERICA: CTMS MARKET, BY END-USER, 2016-2021 (USD MILLION)
• TABLE - 20
NORTH AMERICA: CTMS MARKET, BY TYPE, 2016-2021 (USD MILLION)
• TABLE - 21
NORTH AMERICA: CTMS MARKET, BY DELIVERY MODE, 2016-2021 (USD MILLION)
• TABLE - 22
NORTH AMERICA: CTMS MARKET, BY COMPONENT, 2016-2021 (USD MILLION)
• TABLE - 23
EUROPE: CTMS MARKET, BY END-USER, 2016-2021 (USD MILLION)
• TABLE - 24
EUROPE: CTMS MARKET, BY TYPE, 2016-2021 (USD MILLION)
• TABLE - 25
EUROPE: CTMS MARKET, BY DELIVERY MODE, 2016-2021 (USD MILLION)
• TABLE - 26
EUROPE: CTMS MARKET, BY COMPONENT, 2016-2021 (USD MILLION)
• TABLE - 27
APAC: CTMS MARKET, BY END-USER, 2016-2021 (USD MILLION)
• TABLE - 28
APAC: CTMS MARKET, BY TYPE, 2016-2021 (USD MILLION)
• TABLE - 29
APAC: CTMS MARKET, BY DELIVERY MODE, 2016-2021 (USD MILLION)
• TABLE - 30
APAC: CTMS MARKET, BY COMPONENT, 2016-2021 (USD MILLION)
sales@marketsandmarkets.com
www.marketsandmarkets.com
15
LIST OF TABLES
• TABLE - 31
ROW: CTMS MARKET, BY END-USER, 2016-2021 (USD MILLION)
• TABLE - 32
ROW: CTMS MARKET, BY TYPE, 2016-2021 (USD MILLION)
• TABLE - 33
ROW: CTMS MARKET, BY DELIVERY MODE, 2016-2021 (USD MILLION)
• TABLE - 34
ROW: CTMS MARKET, BY COMPONENT, 2016-2021 (USD MILLION)
•
sales@marketsandmarkets.com
www.marketsandmarkets.com
16
LIST OF FIGURES
• FIGURE - 1
CTMS MARKET SHARE, BY END USER, 2016
• FIGURE - 2
CTMS MARKET SHARE BY END-USER (2016-2021)
• FIGURE - 3
R&D EXPENDITURE OF TOP 10 PHARMACEUTICAL COMPANIES, 2013 VS. 2014 (USD MILLION)
• FIGURE - 4
CTMS MARKET SHARE FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY REGION (2016)
• FIGURE - 5
CRO SERVICES COVER THE ENTIRE DRUG DEVELOPMENT SPECTRUM
• FIGURE - 6
STRATEGIC ALLIANCES BETWEEN CROS AND PHARMA COMPANIES (2011-2015)
• FIGURE - 7
CTMS MARKET SHARE FOR CONTRACT RESEARCH ORGANIZATIONS (CRO), BY REGION (2016)
• FIGURE - 8
CTMS MARKET SHARE FOR MEDICAL DEVICE COMPANIES, BY REGION (2016)
• FIGURE - 9
CTMS MARKET SHARE FOR OTHER END USERS, BY REGION (2016)
• FIGURE - 10
GLOBAL CTMS MARKET SIZE, BY MODE OF DELIVERY (2016)
• FIGURE - 11
WEB-HOSTED (ON-DEMAND) SEGMENT TO DOMINATE THE GLOBAL CTMS SOLUTIONS MARKET IN 2016
• FIGURE - 12
WEB-HOSTED (ON-DEMAND) CTMS MARKET SHARE, BY GEOGRAPHY (2016)
• FIGURE - 13
LICENSED ENTERPRISE (ON-PREMISE) CTMS MARKET SHARE, BY GEOGRAPHY (2016)
• FIGURE - 14
CLOUD-BASED (SAAS) MARKET SHARE, BY GEOGRAPHY (2016)
• FIGURE - 15
GLOBAL CTMS MARKET SIZE, BY COMPONENT, 2016 VS. 2021
• FIGURE - 16
SOFTWARE MARKET SHARE, BY GEOGRAPHY (2016)
• FIGURE - 17
SERVICES MARKET SHARE, BY GEOGRAPHY (2016)
• FIGURE - 18
GLOBAL CTMS MARKET SHARE, BY TYPE, 2016 VS. 2021
• FIGURE - 19
ENTERPRISE CTMS MARKET SHARE, BY GEOGRAPHY (2016)
• FIGURE - 20
SITE CTMS MARKET SHARE, BY GEOGRAPHY (2016)
• FIGURE - 21
CTMS MARKET, BY GEOGRAPHY (2016)
• FIGURE - 22
TOTAL NUMBER OF ONGOING CLINICAL TRIALS, BY REGION (JUNE 2016)
• FIGURE - 23
U.S.: PRESENCE OF HIGH NUMBER OF ORGANIZATIONS FROM DEMAND SIDENUMBER OF BIOTECHNOLOGY R&D ORGANIZATIONS, BY STATE (2014)
• FIGURE - 24
NORTH AMERICA: CTMS MARKET SHARE, BY END-USER(2016)
• FIGURE – 25
NORTH AMERICA: CTMS MARKET SHARE, BY TYPE (2016)
• FIGURE - 26
NORTH AMERICA: CTMS MARKET SHARE, BY DELIVERY MODE (2016)
• FIGURE - 27
NORTH AMERICA: CTMS MARKET SHARE, BY COMPONENT (2016)
• FIGURE - 28
EUROPE: PHARMACEUTICAL R&D EXPENDITURE, BY COUNTRY (2012-13), IN TERMS OF USD MILLION
• FIGURE - 29
EUROPE: CTMS MARKET SHARE, BY END-USER(2016)
sales@marketsandmarkets.com
www.marketsandmarkets.com
17
LIST OF FIGURES
• FIGURE - 30
EUROPE: CTMS MARKET SHARE, BY TYPE (2016)
• FIGURE - 31
EUROPE: CTMS MARKET SHARE, BY DELIVERY MODE (2016)
• FIGURE - 32
EUROPE: CTMS MARKET SHARE, BY COMPONENT (2016)
• FIGURE - 33
APAC: CTMS MARKET SHARE, BY END-USER(2016)
• FIGURE - 34
APAC: CTMS MARKET SHARE, BY TYPE (2016)
• FIGURE - 35
APAC: CTMS MARKET SHARE, BY DELIVERY MODE (2016)
• FIGURE - 36
APAC: CTMS MARKET SHARE, BY COMPONENT (2016)
• FIGURE - 37
ROW: CTMS MARKET SHARE, BY END-USER(2016)
• FIGURE - 38
ROW: CTMS MARKET SHARE, BY TYPE (2016)
• FIGURE - 39
ROW: CTMS MARKET SHARE, BY DELIVERY MODE (2016)
• FIGURE - 40
ROW: CTMS MARKET SHARE, BY COMPONENT (2016)
• FIGURE - 41
COMPETITIVE SITUATION AND TRENDS
• FIGURE - 42
GEOGRAPHIC REVENUE MIX OF THE LEADING MARKET PLAYERS
• FIGURE - 43
ORACLE CORPORATION: COMPANY SNAPSHOT
• FIGURE - 44
MEDIDATA SOLUTIONS, INC.: COMPANY SNAPSHOT
• FIGURE - 45
PAREXEL INTERNATIONAL CORPORATION : COMPANY SNAPSHOT
• FIGURE - 46
MERGE HEALTHCARE INCORPORATED : COMPANY SNAPSHOT
• FIGURE - 47
DATATRAK INTERNATIONAL, INC. : COMPANY SNAPSHOT
• FIGURE - 48
VEEVA SYSTEMS, INC. : COMPANY SNAPSHOT
•
sales@marketsandmarkets.com
www.marketsandmarkets.com
18
SAMPLE TABLES
TABLE 1
CTMS MARKET SIZE FOR OTHERS, BY REGION, 2014-2021 (USD MILLION) 2014
2015
2016-e
2021-p
CAGR (2016–2021)
North America
xx.x
xx.x
xx.x
xx.x
xx.x%
Europe
xx.x
xx.x
xx.x
xx.x
xx.x%
APAC
xx.x
xx.x
xx.x
xx.x
xx.x%
RoW
xx.x
xx.x
xx.x
xx.x
xx.x%
TOTAL
xx.x
xx.x
xx.x
xx.x
xx.x%
COMPANY SIZE
Source: : Annual Reports, SEC Filings, Press Releases, Associated Journals and Articles, Expert Interviews, and MarketsandMarkets Analysis
TABLE 2 SITE CTMS MARKET SIZE, BY GEOGRAPHY, 2014–2021 (USD MILLION) 2014
2015
2016-e
2021-p
CAGR (2016–2021)
North America
xx.x
xx.x
xx.x
xx.x
xx.x%
Europe
xx.x
xx.x
xx.x
xx.x
xx.x%
APAC
xx.x
xx.x
xx.x
xx.x
xx.x%
RoW
xx.x
xx.x
xx.x
xx.x
xx.x%
TOTAL
xx.x
xx.x
xx.x
xx.x
xx.x%
GEOGRAPHY
Source: : Annual Reports, SEC Filings, Press Releases, Associated Journals and Articles, Expert Interviews, and MarketsandMarkets Analysis
TABLE 3
NORTH AMERICA: CTMS MARKET, BY END-USER, 2016-2021 (USD MILLION) 2014
2015
2016-e
2021-p
CAGR (2016–2021)
Pharmaceutical & biopharma companies
xx.x
xx.x
xx.x
xx.x
xx.x%
Clinical Research Organizations
xx.x
xx.x
xx.x
xx.x
xx.x%
Medical device companies
xx.x
xx.x
xx.x
xx.x
xx.x%
Others
xx.x
xx.x
xx.x
xx.x
xx.x%
TOTAL
xx.x
xx.x
xx.x
xx.x
xx.x%
END-USER
Source: : Annual Reports, SEC Filings, Press Releases, Associated Journals and Articles, Expert Interviews, and MarketsandMarkets Analysis
sales@marketsandmarkets.com
www.marketsandmarkets.com
19
APPENDIX
KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL •
Knowledge Store contains MarketsandMarkets’ unique market insights. As a subscriber you have access to all of the published titles and any new ones added over the course of the subscription period. You can subscribe to specific number of reports or domains of your interest. • KNOWLEDGE STORE ENABLES YOU TO:
•
•
View & download all subscribed reports from a single, online platform
•
•
Contact our analysts to answer any questions related to our reports or request a custom research
•
•
Share comments on specific reports with the other users of your organization
•
•
Suggest titles/topics to our research teams that you would like us to cover in our future reports
•
•
Identify reports published on the high growth markets within your industry
•
Get started now by requesting a demo and learning more about Knowledge store - https://www.mnmks.com/ • FIG: MARKETSANDMARKETS KNOWLEDGE STORE SNAPSHOT
•
•
sales@marketsandmarkets.com
www.marketsandmarkets.com
20
APPENDIX
• FIG: MARKETSANDMARKETS KNOWLEDGE STORE: HEALTHCARE IT INDUSTRY SNAPSHOT •
•
sales@marketsandmarkets.com
www.marketsandmarkets.com
21
RELATED REPORTS
RELATED REPORTS SR. NO.
REPORT TITLE
PUBLISHED DATE
1
ECLINICAL SOLUTIONS MARKET By Product (CDMS, EDC, CTMS, eCOA, Analytics, RTMS, eTMF, Safety), Delivery Mode (Web Hosted, On-premise, Cloud-based), Clinical Trial Phases, End User (Pharma/Biopharma Companies, CROs, Hospitals) Global Forecast to 2020
2
Bioinformatics Market By Sector (Molecular Medicine, Agriculture, Forensic, Animal, Research & Gene Therapy), Segment (Sequencing Platforms, Knowledge Management & Data Analysis) & Application (Genomics, Proteomics & Metabolomics) Global Forecast to 2020
February 2016
April 2015
11
ww
w.m
ark
ets
an
sales@marketsandmarkets.com
dm
ark
ets
m .co
www.marketsandmarkets.com
22
ABOUT MNM
MarketsandMarkets is a global market research and consulting company. It is World’s No. 1 in terms of premium market research studies published annually. Serving as a business intelligence partner to Fortune 500 companies across the world, it provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers seventeen industry verticals, including advanced materials, aerospace and defense, agriculture, automotive and transportation, biotechnology, building and construction, chemicals, energy and power, food and beverages, industrial automation, medical devices, mining, minerals and metals, packaging, pharmaceuticals, semiconductor and electronics, and telecommunications and IT.
Copyright © 2016 MarketsandMarkets All Rights Reserved. This document contains highly confidential information and is the sole property of MarketsandMarkets. No part of it may be circulated, copied, quoted, or otherwise reproduced without the approval of MarketsandMarkets.
DISCLAIMER: MarketsandMarkets strategic analysis services are limited publications containing valuable market information provided to a select group of customers in response to orders. Our customers acknowledge, when ordering, that MarketsandMarkets strategic analysis services are for our customers’ internal use and not for general publication or disclosure to third parties. Quantitative market information is based primarily on interviews and therefore, is subject to fluctuation. MarketsandMarkets does not endorse any vendor, product or service depicted in its research publications. MarketsandMarkets strategic analysis publications consist of the opinions of MarketsandMarkets’ research and should not be construed as statements of fact. MarketsandMarkets disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose. MarketsandMarkets takes no responsibility for any incorrect information supplied to us by manufacturers or users. All trademarks, copyrights and other forms of intellectual property belong to their respective owners and may be protected by copyright. Under no circumstance may any of these be reproduced in any form without the prior written agreement of their owner. No part of this strategic analysis service may be given, lent, resold or disclosed to non-customers without written permission. Reproduction and/or transmission in any form and by any means including photocopying, mechanical, electronic, recording or otherwise, without the permission of the publisher is prohibited.
For information regarding permission, contact: 1-888-600-6441 sales@marketsandmarkets.com
sales@marketsandmarkets.com
www.marketsandmarkets.com
23